SU11248

sunitinib malate · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SU11248, covering 2009-09-28 to 2022-11-22. Get the full timeline:

Most recent: Clinical Trial Update: SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer [Phase 2]